<--- Back to Details
First PageDocument Content
Health / Sexually transmitted diseases and infections / HIV/AIDS / Antiseptics / Microbicides for sexually transmitted diseases / Gilead Sciences / Pre-exposure prophylaxis / Vaginal microbicide / BufferGel / Microbicides / Medicine / Microbiology
Date: 2009-11-12 16:05:27
Health
Sexually transmitted diseases and infections
HIV/AIDS
Antiseptics
Microbicides for sexually transmitted diseases
Gilead Sciences
Pre-exposure prophylaxis
Vaginal microbicide
BufferGel
Microbicides
Medicine
Microbiology

HIV/STI Prevention Research and Development: October 2009 Pipeline Update of Microbicide and PrEP Candidates* Number of microbicide and PrEP candidates in clinical trials: 11 • Total number of ARV-based HIV prevention

Add to Reading List

Source URL: www.microbicide.org

Download Document from Source Website

File Size: 54,58 KB

Share Document on Facebook

Similar Documents

January 22, 2016  BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. 1. Gilead Sciences, Galapagos Close $2 Billion Deal for Anti­Infla

January 22, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. 1. Gilead Sciences, Galapagos Close $2 Billion Deal for Anti­Infla

DocID: 1rBxh - View Document

Case 3:16-cvDocument 1 FiledPage 1 ofDorian S. Berger, CA State Bar NoDaniel P. Hipskind, CA State Bar No

Case 3:16-cvDocument 1 FiledPage 1 ofDorian S. Berger, CA State Bar NoDaniel P. Hipskind, CA State Bar No

DocID: 1rqYi - View Document

March 4, 2016  BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. Sponsored By:

March 4, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. Sponsored By:

DocID: 1rdax - View Document

Microsoft Word - GILEAD BRIEFING

Microsoft Word - GILEAD BRIEFING

DocID: 1r2Vm - View Document

Patient Name:________________________________________ Date of Birth:__________________  Truvada® for Pre-Exposure Prophylaxis (PrEP) Medication Assistance Program Page 1 of 4

Patient Name:________________________________________ Date of Birth:__________________ Truvada® for Pre-Exposure Prophylaxis (PrEP) Medication Assistance Program Page 1 of 4

DocID: 1qMRc - View Document